Compared with other key drivers, CTNNB1 mutations were significantly associated with EGFR mutations, which occurred in 41.7% (n = 15) of patients with CTNNB1-mutated NSCLC (Fig 1C). Here, EGFR is linked to non-small cell lung carcinoma.